Author:
Gediya Piyush,Vyas Vivek K.,Carafa Vincenzo,Sitwala Nikum,Della Torre Laura,Poziello Angelita,Kurohara Takashi,Suzuki Takayoshi,Sanna Vinod,Raguraman Varalakshmi,Suthindhiran K.,Ghosh Debarpan,Bhatia Dhiraj,Altucci Lucia,Ghate Manjunath D.
Funder
Universita degli Studi della Campania Luigi Vanvitelli
Subject
Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry
Reference52 articles.
1. Histone deacetylases and cancer: causes and therapies;Marks;Nat. Rev. Cancer.,2001
2. T.C.S. Ho, A.H.Y. Chan, A. Ganesan, Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight, J. Med. Chem. (2020).
3. Trials with “epigenetic” drugs: an update;Nebbioso;Mol. Oncol.,2012
4. c-Myc modulation and acetylation is a key HDAC inhibitor target in cancer;Nebbioso;Clin. Cancer Res. an Off. J. Am. Assoc. Cancer Res.,2017
5. Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors;Delcuve;Clin. Epigenet.,2012
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献